ADM and neoplasm: Earlier studies have shown ADM22-52, small moleculeantagonist, anti-ADM antibody, and anti-CLR/RAMP antibodies block the growth and/ormetastasis of tumor xenografts in animal models [25, 26, 29, 43, 47, 49, 57, 114].